{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:09:10Z","timestamp":1790712550513,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.diagmicrobio.2012.06.030","type":"journal-article","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T04:20:15Z","timestamp":1344918015000},"page":"272-277","source":"Crossref","is-referenced-by-count":55,"title":["In vitro\u2013in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus"],"prefix":"10.1016","volume":"74","author":[{"given":"S.","family":"Krishnan Natesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Cutright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.H.","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1128\/AAC.39.6.1345","article-title":"Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis","volume":"39","author":"Allendoerfer","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0010","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/AAC.01492-08","article-title":"Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole","volume":"53","author":"Beernaert","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13693780902717018","article-title":"Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma","volume":"48","author":"Bellete","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11908-011-0218-4","article-title":"Azole antifungal resistance today: focus on Aspergillus","volume":"13","author":"Bowyer","year":"2011","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0025","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole","volume":"56","author":"Burgel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India","volume":"67","author":"Chowdhary","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0040","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/fmb.11.118","article-title":"Azole resistance in Aspergillus: a growing public health menace","volume":"6","author":"Denning","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/AAC.00301-11","article-title":"In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations","volume":"56","author":"Escribano","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2217\/17460913.2.3.231","article-title":"Posaconazole: a next-generation triazole antifungal","volume":"2","author":"Farowski","year":"2007","journal-title":"Future Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00003495-200868070-00008","article-title":"Posaconazole: a review of its use in the prophylaxis of invasive fungal infections","volume":"68","author":"Frampton","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jac\/42.4.539","article-title":"SCH56592 treatment of murine invasive aspergillosis","volume":"42","author":"Graybill","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jac\/dkg261","article-title":"Improving the mouse model for studying the efficacy of voriconazole","volume":"51","author":"Graybill","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1439-0507.2006.01296.x","article-title":"Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections","volume":"49","author":"Groll","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2180-7-104","article-title":"Improved protocols for functional analysis in the pathogenic fungus Aspergillus flavus","volume":"7","author":"He","year":"2007","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery","volume":"47","author":"Hodiamont","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0090","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/IAI.58.5.1476-1478.1990","article-title":"Use of DBA\/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis","volume":"58","author":"Hector","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2006.08.017","article-title":"Multi-azole resistance in Aspergillus fumigatus","volume":"28","author":"Howard","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1469-0691.2009.02911.x","article-title":"Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis","volume":"16","author":"Howard","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0105","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1128\/AAC.48.10.4063-4066.2004","article-title":"Efficacy of posaconazole in a murine model of central nervous system aspergillosis","volume":"48","author":"Imai","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0110","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.44.3.780-782.2000","article-title":"Efficacy of SCH56592 in a rabbit model of invasive aspergillosis","volume":"44","author":"Kirkpatrick","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jac\/dkq041","article-title":"Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands","volume":"65","author":"Klaassen","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0125","series-title":"Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","first-page":"M-471","article-title":"Cytochrome P450 14-sterol demethylase mutation dependent triazole cross resistance in Aspergillus fumigatus","author":"Manavathu","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0130","first-page":"M-392","article-title":"Molecular studies on voriconazole-resistance in a clinical isolate of Aspergillus fumigatus","author":"Manavathu","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0135","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/AAC.00931-09","article-title":"Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene","volume":"54","author":"Mavridou","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0140","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.48.7.2747-2750.2004","article-title":"Substitutions at methionine 220 in the 14alpha-sterol demethylase (cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs","volume":"48","author":"Mellado","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0145","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0150","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1080\/13693780500090826","article-title":"Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates","volume":"43","author":"Meneau","year":"2005","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0155","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.46.2.556-557.2002","article-title":"Azole cross-resistance in Aspergillus fumigatus","volume":"46","author":"Mosquera","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0160","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/AAC.48.10.3690-3696.2004","article-title":"Posaconazole is a potent inhibitor of sterol 14-alpha-demethylation in yeasts and molds","volume":"48","author":"Munayyer","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0165","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/AAC.47.5.1719-1726.2003","article-title":"Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole","volume":"47","author":"Nascimento","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1439-0507.2006.01301.x","article-title":"Posaconazole for treatment of refractory invasive fungal disease","volume":"49","author":"Notheis","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0175","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.41.7.1504","article-title":"Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus","volume":"41","author":"Oakley","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0180","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1128\/JCM.00329-12","article-title":"Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis","volume":"50","author":"Pelaez","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"1 Suppl.","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0185","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0190","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/JCM.00535-08","article-title":"In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2012.06.030_bb0250","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0195","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0200","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","author":"Snelders","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0205","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/nprot.2006.405","article-title":"Fusion PCR and gene targeting in Aspergillus nidulans","volume":"1","author":"Szewczyk","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0210","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.05394-11","article-title":"Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/INF.0b013e3182037879","article-title":"Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy","volume":"30","author":"Thors","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0220","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(05)70297-8","article-title":"Posaconazole: a broad-spectrum triazole antifungal","volume":"5","author":"Torres","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0225","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0230","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis","volume":"356","author":"Verweij","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0235","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.06.030_bb0245","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.48.2.568-574.2004","article-title":"Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding","volume":"48","author":"Xiao","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312002817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312002817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T14:58:09Z","timestamp":1594565889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889312002817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0732889312002817"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.06.030","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}